BOSTON, Feb. 3, 2022 /PRNewswire/ — GreenLight Biosciences (“GreenLight”), a biotechnology firm devoted to creating ribonucleic acid (RNA) merchandise inexpensive and accessible for human well being and agriculture, and Environmental Influence Acquisition Corp. (Nasdaq: ENVI) (“ENVI”), a particular function acquisition firm, yesterday introduced the closing of their beforehand introduced enterprise mixture.
In reference to the closing, the corporate modified its identify to GreenLight Biosciences Holdings, public-benefit company, with shares of Class A typical inventory and public warrants buying and selling right now on Nasdaq beneath the ticker symbols “GRNA” and “GRNA.WS” respectively. The enterprise mixture was authorised at a particular assembly of ENVI stockholders on February 1, 2022.
GreenLight harnesses the facility of biology to develop RNA-based options for a few of humanity’s best challenges in human well being by mRNA vaccines and therapeutics and in meals manufacturing by RNA crop-protection merchandise. The corporate’s breakthrough cell-free RNA manufacturing platform, which is protected by quite a few patents, permits for cost-effective and scalable manufacturing of RNA.
“Right now an thrilling new chapter begins as we develop into a publicly listed firm and public-benefit company,” stated CEO Andrey Zarur. “We’re thrilled to speed up commercialization by attracting the expertise, investing within the instruments, and scaling our manufacturing infrastructure to proceed creating our platform for design, growth, and manufacturing of unprecedented new purposes for RNA.”
“In creating ENVI, our aim was to accomplice and mix with a high-growth, technology-rich enterprise, propelled by a big market alternative and a enterprise mannequin supporting crucial sustainability initiatives,” stated Dan Coyne, CEO of Environmental Influence Acquisition Corp. “GreenLight has a formidable pipeline of RNA merchandise spanning human, animal, and plant well being, and its distinctive workforce understands what it takes to ship breakthrough expertise to market. We’re extraordinarily happy to have accomplished this transaction, leading to GreenLight turning into a public firm.”
SVB Leerink and Credit score Suisse served as monetary and capital markets advisors to GreenLight and co-placement brokers on the PIPE transaction. Foley Hoag LLP served as authorized advisor to GreenLight. Canaccord Genuity served as monetary advisor and Latham & Watkins LLP served as authorized advisor to Environmental Influence Acquisition Corp.
To rejoice the completion of the enterprise mixture, GreenLight will ring the closing bell at Nasdaq at 4 p.m. ET on February 8, 2022.
About GreenLight Biosciences
GreenLight Biosciences goals to deal with among the world’s greatest issues by delivering on the total potential of RNA for human well being and agriculture. Our RNA platform permits us to analysis, design, and manufacture for human, animal, and plant well being. In human well being, this contains mRNA vaccines and therapeutics. In agriculture, this contains RNA to guard honeybees and a spread of crops. The corporate’s platform is protected by quite a few patents. GreenLight’s human well being product candidates are within the pre-clinical stage, and its product candidates for the agriculture market are within the early levels of growth or regulatory assessment. GreenLight is a public profit company that trades beneath the ticker GRNA on Nasdaq. For extra info, go to GreenLight’s web site.
About Environmental Influence Acquisition Company
Environmental Influence Acquisition Corp. is a Particular Objective Acquisition Firm. The Firm is sponsored by CG Investments Inc. VI, an affiliate of Canaccord Genuity, which manages a number of funding automobiles.
This press launch incorporates “forward-looking statements” inside the which means of the secure harbor provisions of the U.S. Personal Securities Litigation Reform Act of 1995, with respect to the proposed transaction between GreenLight Biosciences, Inc. (“GreenLight”) and Environmental Influence Acquisition Corp. (“ENVI”). These forward-looking statements typically are recognized by the phrases “imagine,” “challenge,” “anticipate,” “anticipate,” “estimate,” “intend,” “technique,” “future,” “alternative,” “plan,” “might,” “ought to,” “will,” “would,” “will likely be,” “will proceed,” “will possible end result” and related expressions. Many elements might trigger precise future occasions to vary materially from the forward-looking statements on this press launch, together with however not restricted to the danger that the transaction might not be accomplished in a well timed method or in any respect, which can adversely have an effect on the worth of ENVI’s securities and the impact of the announcement or pendency of the transaction on GreenLight’s enterprise relationships, working outcomes, and enterprise typically. Ahead-looking statements converse solely as of the date they’re made. Readers are cautioned to not put undue reliance on forward-looking statements, and ENVI and GreenLight assume no obligation and don’t intend to replace or revise these forward-looking statements, whether or not because of new info, future occasions or in any other case.
View unique content material to obtain multimedia:https://www.prnewswire.com/news-releases/greenlight-biosciences-begins-trading-today-as-nasdaq-grna-on-the-closing-of-its-business-combination-with-environmental-impact-acquisition-corp-301474999.html
SOURCE GreenLight Biosciences, Inc.